300171 东富龙
交易中 07-23 14:41:27
资讯
新帖
简况
东富龙:立足提质增效提升产品质量与订单质量
证券之星 · 07-11
东富龙:立足提质增效提升产品质量与订单质量
医疗器械行业8日主力净流出3.11亿元,圣湘生物、东富龙居前
金融界 · 07-08
医疗器械行业8日主力净流出3.11亿元,圣湘生物、东富龙居前
东富龙:积极借鉴优秀上市企业市值管理提升方法
证券之星 · 07-07
东富龙:积极借鉴优秀上市企业市值管理提升方法
东富龙与通化东宝签署战略合作协议
DoNews · 07-01
东富龙与通化东宝签署战略合作协议
东富龙新注册《基于机械手的拆内包机控制系统V1.0》项目的软件著作权
证券之星 · 06-30
东富龙新注册《基于机械手的拆内包机控制系统V1.0》项目的软件著作权
东富龙:坚守专业技术服务于生物医药的使命
证券之星 · 06-26
东富龙:坚守专业技术服务于生物医药的使命
医疗器械创新政策利好来了,迈得医疗、东富龙、奕瑞科技、英诺激光、天华新能、康弘药业等医疗器械题材产业链企业整理
金融界 · 06-21
医疗器械创新政策利好来了,迈得医疗、东富龙、奕瑞科技、英诺激光、天华新能、康弘药业等医疗器械题材产业链企业整理
东富龙:公司将在法律、法规及监管规则允许方式内开展常态化、持续化的市值管理工作
证券之星 · 06-20
东富龙:公司将在法律、法规及监管规则允许方式内开展常态化、持续化的市值管理工作
东富龙获得实用新型专利授权:“一种取瓶入托装置”
证券之星 · 06-19
东富龙获得实用新型专利授权:“一种取瓶入托装置”
东富龙获得实用新型专利授权:“一种塑料瓶焊盖机”
证券之星 · 06-17
东富龙获得实用新型专利授权:“一种塑料瓶焊盖机”
【疫苗股震荡拉升 沃森生物涨超10%】疫苗概念股盘中拉升,沃森生物、东富龙涨超10%,塞力医疗涨停,智飞生物、昭衍新药、康泰生物、华北制药涨超5%,冠昊生物、华兰疫苗等跟涨。
金融界 · 06-17
【疫苗股震荡拉升 沃森生物涨超10%】疫苗概念股盘中拉升,沃森生物、东富龙涨超10%,塞力医疗涨停,智飞生物、昭衍新药、康泰生物、华北制药涨超5%,冠昊生物、华兰疫苗等跟涨。
东富龙:公司深耕生物医药行业三十余载提供一体化智能解决方案
证券之星 · 06-10
东富龙:公司深耕生物医药行业三十余载提供一体化智能解决方案
东富龙:公司高度重视以提高上市公司质量为核心的市值管理
证券之星 · 06-09
东富龙:公司高度重视以提高上市公司质量为核心的市值管理
东富龙:公司自成立以来深耕生物医药行业围绕生物医药产业链积极布局
证券之星 · 05-26
东富龙:公司自成立以来深耕生物医药行业围绕生物医药产业链积极布局
每周股票复盘:东富龙(300171)2024年年度权益分派即将实施
证券之星 · 05-24
每周股票复盘:东富龙(300171)2024年年度权益分派即将实施
东富龙:上市公司估值受所处行业、资金偏好等多种因素影响
证券之星 · 05-19
东富龙:上市公司估值受所处行业、资金偏好等多种因素影响
东富龙获得发明专利授权:“一种西林瓶加塞装置”
证券之星 · 05-16
东富龙获得发明专利授权:“一种西林瓶加塞装置”
东富龙:公司已建立完善治理体系和内部控制环境
证券之星 · 05-15
东富龙:公司已建立完善治理体系和内部控制环境
东富龙获得实用新型专利授权:“一种球形颗粒分粒装置”
证券之星 · 05-12
东富龙获得实用新型专利授权:“一种球形颗粒分粒装置”
东富龙:重组LR3 IGF-1细胞培养补充物具有出色性能可与进口产品媲美
证券之星 · 05-09
东富龙:重组LR3 IGF-1细胞培养补充物具有出色性能可与进口产品媲美
加载更多
公司概况
公司名称:
东富龙科技集团股份有限公司
所属行业:
专用设备制造业
上市日期:
2011-02-01
主营业务:
东富龙科技集团股份有限公司的主营业务是为全球制药企业提供制药工艺、核心装备、系统工程整体解决方案。公司的主要产品是生物工艺板块、制剂板块、工程整体解决方案板块、食品装备工程板块。
发行价格:
86.00
{"stockData":{"symbol":"300171","market":"SZ","secType":"STK","nameCN":"东富龙","latestPrice":13.57,"timestamp":1753252887000,"preClose":13.61,"halted":0,"volume":8904452,"delay":0,"changeRate":-0.0029,"floatShares":563000000,"shares":766000000,"eps":0.1953,"marketStatus":"交易中","change":-0.04,"latestTime":"07-23 14:41:27","open":13.61,"high":13.89,"low":13.53,"amount":122000000,"amplitude":0.0265,"askPrice":13.57,"askSize":217,"bidPrice":13.55,"bidSize":206,"shortable":0,"etf":0,"ttmEps":0.1953,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1753254000000},"marketStatusCode":2,"adr":0,"adjPreClose":13.61,"symbolType":"stock","openAndCloseTimeList":[[1753234200000,1753241400000],[1753246800000,1753254000000]],"highLimit":14.97,"lowLimit":12.25,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":765828040,"isCdr":false,"pbRate":1.33,"roa":"--","peRate":69.482847,"roe":"0.25%","epsLYR":0.26,"committee":0.315268,"marketValue":10392000000,"turnoverRate":0.0158,"status":1,"floatMarketCap":7635000000},"requestUrl":"/m/hq/s/300171","defaultTab":"news","newsList":[{"id":"2550899079","title":"东富龙:立足提质增效提升产品质量与订单质量","url":"https://stock-news.laohu8.com/highlight/detail?id=2550899079","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550899079?lang=zh_cn&edition=full","pubTime":"2025-07-11 15:21","pubTimestamp":1752218491,"startTime":"0","endTime":"0","summary":"证券之星消息,东富龙07月11日在投资者关系平台上答复投资者关心的问题。2025年度,公司全员上下在各自岗位积极落实“提质增效”的年度经营主题,立足全方位提升产品质量、订单质量、客户满意度、工作效率。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071100018676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0},{"id":"2549515973","title":"医疗器械行业8日主力净流出3.11亿元,圣湘生物、东富龙居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2549515973","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549515973?lang=zh_cn&edition=full","pubTime":"2025-07-08 15:41","pubTimestamp":1751960514,"startTime":"0","endTime":"0","summary":"7月8日,医疗器械行业上涨0.45%,今日主力资金流出3.11亿元,成分股71只上涨,26只下跌。主力资金净流出居前的分别为圣湘生物、东富龙、爱朋医疗、中红医疗、冠昊生物。序号代码名称最新价涨跌幅主力净流入主力净占比1300760迈瑞医疗217.330.431.35亿元11.61%2300003乐普医疗15.792.339668.61万元8.08%3300318博晖创新6.356.373225.98万元12.37%4300685艾德生物22.845.52473.98万元5.84%5301234五洲医疗37.24-3.522323.62万元7.01%6688317之江生物19.540.511114.66万元8.17%7688298东方生物27.813.611021.96万元7.28%8300439美康生物10.832.27933.09万元8.82%9300869康泰医学14.851.57881.13万元9.23%10600807济高发展3.3-1.79670.07万元2.03%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/08154151554821.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0251","09996","09997","BK1100","BK1222","159883","BK0239","300171","BK1574","688289","BK1583"],"gpt_icon":0},{"id":"2549958560","title":"东富龙:积极借鉴优秀上市企业市值管理提升方法","url":"https://stock-news.laohu8.com/highlight/detail?id=2549958560","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549958560?lang=zh_cn&edition=full","pubTime":"2025-07-07 15:45","pubTimestamp":1751874316,"startTime":"0","endTime":"0","summary":"证券之星消息,东富龙07月07日在投资者关系平台上答复投资者关心的问题。公司二级市场股价走势受公司所处行业、市场环境及投资者偏好等多方面因素影响,公司高度关注股东利益和合理建议,一方面将努力提升公司业绩以稳定的分红回馈投资者;另一方面将积极借鉴学习优秀上市企业的市值管理提升方法,开展常态化、持续化的市值管理工作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070700016233.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"gpt_icon":0},{"id":"2548404441","title":"东富龙与通化东宝签署战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2548404441","media":"DoNews","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548404441?lang=zh_cn&edition=full","pubTime":"2025-07-01 08:58","pubTimestamp":1751331482,"startTime":"0","endTime":"0","summary":"7月1日,东富龙与通化东宝正式签署战略合作协议。双方将在产品研发、设备创新、工艺优化及商业合作等多个维度展开深度合作,重点推动糖尿病治疗领域的技术进步和产业发展。此次合作旨在整合优势资源,加速技术创新,提升行业竞争力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507010900129531de36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507010900129531de36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["300171","BK0239","BK0251","BK0196","BK0188","600867"],"gpt_icon":0},{"id":"2548014346","title":"东富龙新注册《基于机械手的拆内包机控制系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2548014346","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548014346?lang=zh_cn&edition=full","pubTime":"2025-07-01 01:50","pubTimestamp":1751305818,"startTime":"0","endTime":"0","summary":"证券之星消息,近日东富龙新注册了《基于机械手的拆内包机控制系统V1.0》项目的软件著作权。今年以来东富龙新注册软件著作权2个,较去年同期增加了100%。结合公司2024年年报财务数据,2024年公司在研发方面投入了3.46亿元,同比减8.76%。通过天眼查大数据分析,东富龙科技集团股份有限公司共对外投资了22家企业,参与招投标项目722次;财产线索方面有商标信息69条,专利信息1679条,著作权信息67条;此外企业还拥有行政许可141个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070100002377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"gpt_icon":0},{"id":"2546520949","title":"东富龙:坚守专业技术服务于生物医药的使命","url":"https://stock-news.laohu8.com/highlight/detail?id=2546520949","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546520949?lang=zh_cn&edition=full","pubTime":"2025-06-26 15:33","pubTimestamp":1750923227,"startTime":"0","endTime":"0","summary":"证券之星消息,东富龙(300171)06月26日在投资者关系平台上答复投资者关心的问题。投资者提问:公司微信公众号经常发布新技术,新产品。但业绩与股价为什么这样?是新技术与新产品得不到市场的认可?东富龙回复:您好,公司坚守“专业技术服务于生物医药” 的使命,凭借优秀的研发创新及技术成果转化能力,根据客户不同应用场景需求,开发具有行业前沿技术的先进工艺设备。经过三十余年的品牌沉淀及技术积累,公司产品及技术在用户端有较高认可及满意度。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062600019553.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399441","300171","BK0251","161726"],"gpt_icon":0},{"id":"2545059489","title":"医疗器械创新政策利好来了,迈得医疗、东富龙、奕瑞科技、英诺激光、天华新能、康弘药业等医疗器械题材产业链企业整理","url":"https://stock-news.laohu8.com/highlight/detail?id=2545059489","media":"金融界","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545059489?lang=zh_cn&edition=full","pubTime":"2025-06-21 23:17","pubTimestamp":1750519048,"startTime":"0","endTime":"0","summary":"医疗器械出现政策利好,标志着我国高端医疗器械产业进入加速创新周期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.jrj.com.cn/2025/06/21231751224701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688301","BK1222","09997","BK0214","09996","301021","BK0070","BK0239","BK0197","300171","BK0196","159883","BK1583","300390","688310","BK1574","BK0251","BK1100","002773"],"gpt_icon":0},{"id":"2544466001","title":"东富龙:公司将在法律、法规及监管规则允许方式内开展常态化、持续化的市值管理工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2544466001","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544466001?lang=zh_cn&edition=full","pubTime":"2025-06-20 16:00","pubTimestamp":1750406455,"startTime":"0","endTime":"0","summary":"证券之星消息,东富龙06月20日在投资者关系平台上答复投资者关心的问题。公司理解投资者对股价的关切,在市值管理方面也愿意倾听广大投资者的意见与建议。公司将在法律、法规及监管规则允许方式内开展常态化、持续化的市值管理工作,同时积极借鉴学习优秀上市企业的市值管理提升方法。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062000020648.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0},{"id":"2544195069","title":"东富龙获得实用新型专利授权:“一种取瓶入托装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2544195069","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544195069?lang=zh_cn&edition=full","pubTime":"2025-06-20 02:23","pubTimestamp":1750357428,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示东富龙新获得一项实用新型专利授权,专利名为“一种取瓶入托装置”,专利申请号为CN202421728254.0,授权日为2025年6月20日。今年以来东富龙新获得专利授权53个,较去年同期减少了13.11%。通过天眼查大数据分析,东富龙科技集团股份有限公司共对外投资了22家企业,参与招投标项目722次;财产线索方面有商标信息69条,专利信息1679条,著作权信息67条;此外企业还拥有行政许可141个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062000001081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0},{"id":"2544999760","title":"东富龙获得实用新型专利授权:“一种塑料瓶焊盖机”","url":"https://stock-news.laohu8.com/highlight/detail?id=2544999760","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544999760?lang=zh_cn&edition=full","pubTime":"2025-06-18 02:56","pubTimestamp":1750186570,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示东富龙新获得一项实用新型专利授权,专利名为“一种塑料瓶焊盖机”,专利申请号为CN202421538575.4,授权日为2025年6月3日。今年以来东富龙新获得专利授权52个,较去年同期减少了14.75%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061800001271.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0},{"id":"2544389879","title":"【疫苗股震荡拉升 沃森生物涨超10%】疫苗概念股盘中拉升,沃森生物、东富龙涨超10%,塞力医疗涨停,智飞生物、昭衍新药、康泰生物、华北制药涨超5%,冠昊生物、华兰疫苗等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2544389879","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544389879?lang=zh_cn&edition=full","pubTime":"2025-06-17 09:55","pubTimestamp":1750125343,"startTime":"0","endTime":"0","summary":"疫苗概念股盘中拉升,沃森生物、东富龙涨超10%,塞力医疗涨停,智飞生物、昭衍新药、康泰生物、华北制药涨超5%,冠昊生物、华兰疫苗等跟涨。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/17095551106267.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159646","BK0077","600812","BK0042","LU2580892789.USD","300142","300238","BK0239","BK0070","BK0196","LU1064130708.USD","603716","300122","BK0201","300601","LU1064131003.USD","BK0086","301207","BK0191","BK0188","BK1141","BK0250","BK0251","LU1328615791.USD","300171","06127","LU2148510915.USD","LU2580892862.HKD","BK1576","BK0046","BK0216","BK0028","603127"],"gpt_icon":0},{"id":"2542395840","title":"东富龙:公司深耕生物医药行业三十余载提供一体化智能解决方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2542395840","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542395840?lang=zh_cn&edition=full","pubTime":"2025-06-10 16:00","pubTimestamp":1749542447,"startTime":"0","endTime":"0","summary":"证券之星消息,东富龙(300171)06月10日在投资者关系平台上答复投资者关心的问题。投资者提问:公司的设备有没有用到创新药制造上,有无跟创新药上市公司合作东富龙回复:您好,公司深耕生物医药行业三十余载,拥有丰富的行业经验及客户资源,能为全球制药企业提供设备+耗材+工程一体化的智能解决方案,可覆盖传统小分子化药、生物大分子、细胞药物、核酸药物等药物形式的生产制造。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061000021676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161726","300171","BK0251","399441"],"gpt_icon":0},{"id":"2542808109","title":"东富龙:公司高度重视以提高上市公司质量为核心的市值管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2542808109","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542808109?lang=zh_cn&edition=full","pubTime":"2025-06-09 15:07","pubTimestamp":1749452840,"startTime":"0","endTime":"0","summary":"证券之星消息,东富龙06月09日在投资者关系平台上答复投资者关心的问题。公司高度重视以提高上市公司质量为核心的市值管理,也理解投资者对股价的关切,通过业绩说明会、机构调研、互动易平台等多种渠道与投资者保持良性沟通,广泛听取投资者的意见与建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060900013227.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"gpt_icon":0},{"id":"2538717401","title":"东富龙:公司自成立以来深耕生物医药行业围绕生物医药产业链积极布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2538717401","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538717401?lang=zh_cn&edition=full","pubTime":"2025-05-26 17:21","pubTimestamp":1748251278,"startTime":"0","endTime":"0","summary":"证券之星消息,东富龙05月26日在投资者关系平台上答复投资者关心的问题。公司将持续开拓创新,打造产品差异化优势,进一步提升自身竞争力,提高公司盈利能力来回报投资者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052600022760.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161726","BK0251","300171","399441"],"gpt_icon":0},{"id":"2537716778","title":"每周股票复盘:东富龙(300171)2024年年度权益分派即将实施","url":"https://stock-news.laohu8.com/highlight/detail?id=2537716778","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537716778?lang=zh_cn&edition=full","pubTime":"2025-05-24 15:25","pubTimestamp":1748071512,"startTime":"0","endTime":"0","summary":"截至2025年5月23日收盘,东富龙报收于11.82元,较上周的12.11元下跌2.39%。本周,东富龙5月20日盘中最高价报12.17元。回购专用证券账户股份数量不参与本次权益分派。本次权益分派股权登记日为2025年5月29日,除权除息日为2025年5月30日。A股股东现金红利将于2025年5月30日通过股东托管证券公司直接划入其资金账户。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052400012793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0},{"id":"2536503412","title":"东富龙:上市公司估值受所处行业、资金偏好等多种因素影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2536503412","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536503412?lang=zh_cn&edition=full","pubTime":"2025-05-19 16:27","pubTimestamp":1747643254,"startTime":"0","endTime":"0","summary":"证券之星消息,东富龙05月19日在投资者关系平台上答复投资者关心的问题。上市公司估值受所处行业、资金偏好等多种因素影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051900021310.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0},{"id":"2536834409","title":"东富龙获得发明专利授权:“一种西林瓶加塞装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2536834409","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536834409?lang=zh_cn&edition=full","pubTime":"2025-05-17 03:03","pubTimestamp":1747422236,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示东富龙新获得一项发明专利授权,专利名为“一种西林瓶加塞装置”,专利申请号为CN202211571778.9,授权日为2025年5月16日。本发明解决了使用fit cap铝盖胶塞在西林瓶加塞时的问题。今年以来东富龙新获得专利授权47个,较去年同期减少了9.62%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051700002667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"gpt_icon":0},{"id":"2535034840","title":"东富龙:公司已建立完善治理体系和内部控制环境","url":"https://stock-news.laohu8.com/highlight/detail?id=2535034840","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535034840?lang=zh_cn&edition=full","pubTime":"2025-05-15 20:48","pubTimestamp":1747313304,"startTime":"0","endTime":"0","summary":"证券之星消息,东富龙05月15日在投资者关系平台上答复投资者关心的问题。我们持股科伦十年了,希望也能在东富龙复制!在郑总的带领下,公司管理团队围绕公司发展战略及经营计划开展相关工作。公司已按照上市公司的治理标准建立了以法人治理结构为核心的现代企业制度,建立与业务开展相适应的内部组织架构,形成了完善的公司治理体系以及健全的内部控制环境,为公司长期稳健发展提供保障。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051500034868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"gpt_icon":0},{"id":"2535783404","title":"东富龙获得实用新型专利授权:“一种球形颗粒分粒装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2535783404","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535783404?lang=zh_cn&edition=full","pubTime":"2025-05-13 02:50","pubTimestamp":1747075809,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示东富龙新获得一项实用新型专利授权,专利名为“一种球形颗粒分粒装置”,专利申请号为CN202420807564.5,授权日为2025年5月13日。今年以来东富龙新获得专利授权42个,较去年同期减少了16%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051300001471.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"gpt_icon":0},{"id":"2534483171","title":"东富龙:重组LR3 IGF-1细胞培养补充物具有出色性能可与进口产品媲美","url":"https://stock-news.laohu8.com/highlight/detail?id=2534483171","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534483171?lang=zh_cn&edition=full","pubTime":"2025-05-09 17:30","pubTimestamp":1746783057,"startTime":"0","endTime":"0","summary":"证券之星消息,东富龙05月09日在投资者关系平台上答复投资者关心的问题。投资者提问:重组LR3 IGF-1细胞培养补充物设备 ,什么时候上市 ,可以推动国产替代吗。东富龙回复:您好,公司生命科学事业部推出的新品“重组LR3 IGF-1细胞培养补充物”具有细胞增殖效率高、产物表达量提升、有效维持细胞活性等特点,其出色的性能可以与进口产品相媲美,并且供应更加稳定可靠、工艺适应性强、性价比高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050900027767.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753252892015,"stockEarnings":[{"period":"1week","weight":0.0311},{"period":"1month","weight":0.0658},{"period":"3month","weight":0.1608},{"period":"6month","weight":0.1046},{"period":"1year","weight":0.2296},{"period":"ytd","weight":0.0314}],"compareEarnings":[{"period":"1week","weight":0.0219},{"period":"1month","weight":0.0661},{"period":"3month","weight":0.0866},{"period":"6month","weight":0.1089},{"period":"1year","weight":0.2084},{"period":"ytd","weight":0.0686}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"东富龙科技集团股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"31365人(较上一季度减少6.15%)","perCapita":"17939股","listingDate":"2011-02-01","address":"上海市闵行区都会路1509号4幢","registeredCapital":"76582万元","survey":" 东富龙科技集团股份有限公司的主营业务是为全球制药企业提供制药工艺、核心装备、系统工程整体解决方案。公司的主要产品是生物工艺板块、制剂板块、工程整体解决方案板块、食品装备工程板块。","listedPrice":86},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东富龙(300171)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东富龙(300171)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东富龙,300171,东富龙股票,东富龙股票老虎,东富龙股票老虎国际,东富龙行情,东富龙股票行情,东富龙股价,东富龙股市,东富龙股票价格,东富龙股票交易,东富龙股票购买,东富龙股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东富龙(300171)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东富龙(300171)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}